News Snapshot:
Five research facilities and biotechnology companies in Taiwan are currently developing vaccines for the COVID-19 coronavirus, most of which are expected to enter clinical trials by the end of this year, the Central Epidemic Command Center (CECC) said Wednesday. In addition to the government-run National Health Research Institutes (NHRI) and Academia Sinica, three biotech companies are developing the vaccines, said NHRI President Liang Kung-yee (æ¢è³¡ç¾©), who is also a CECC member. The NHRI could begin human trials in autumn at the earliest, looking into four categories of vaccines through the use of peptides, DNA engineering, recombinant viruses and antigen-based subunit...
